Showing results (91-100 of 115) with videos related to
Sort By:
Pageof 12
Cell Host & Microbe|March 5, 2020
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing LineageChen-Hsiang Shen, Brandon J DeKosky, Yicheng Guo, et al.Nature|December 20, 2013
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIVMario Roederer, Brandon F Keele, Stephen D Schmidt, et al.Science (New York, N.Y.)|September 22, 2017
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaquesLing Xu, Amarendra Pegu, Ercole Rao, et al.The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.Cell Reports|January 5, 2022
Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeysAmarendra Pegu, Ling Xu, Megan E DeMouth, et al.Cell|September 10, 2016
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor RepertoiresMing Tian, Cheng Cheng, Xuejun Chen, et al.Journal of Virology|August 22, 2014
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivoRebecca S Rudicell, Young Do Kwon, Sung-Youl Ko, et al.Cell Reports|April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody ElicitationTongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.Nature|November 25, 2011
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9Jason S McLellan, Marie Pancera, Chris Carrico, et al.Pageof 12